50242-150 : Ocrevus 300 mg/10ml Intravenous Injection


NDC: 50242-150
Labeler: Genentech, Inc.
Product Type: Human Prescription Drug
Drug Name:  Ocrevus
Dosage Form: Intravenous Injection
Application #: BLA761053
Rev. Date: 


NDC Package Codes:

  • 50242-150-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (50242‑150‑01) > 10 ML IN 1 VIAL, SINGLE‑USE

Active Ingredients:

  • Ocrelizumab

Dosage Strength:

  • 300 mg/10mL

Pharmaceutical Classes:

  • CD20-directed Antibody Interactions [MoA]
  • CD20-directed Cytolytic Antibody [EPC]
  • Antibodies
  • Monoclonal [Chemical/Ingredient]
  • Monoclonal
  • Humanized [Chemical/Ingredient]

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 50242-150 QR Code

< Prev: 50242-145Next: 50242-159 >

Related Discussions:

Ocrevus - Burning skin sensation
Has anyone experienced a burning skin sensation from Ocrevus? For me, it is occurring in my back and buttocks. It is wor... 2 replies
Ocrevus infusion time to take effect
How long do I have to wait for the medicine take effect? I still have a migraine and dizziness every day. I first infusi... 2 replies
Ocrevus AWP pricing
I am trying to locate the AWP for Ocrevus. Any ideas? I have not been able to locate it anywhere. Thank you. ## Hi Nan, ... 1 reply




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.